Enovis (ENOV) Other Non Operating Income (2018 - 2026)
Enovis' (ENOV) quarterly Other Non Operating Income came in at $3.3 million in Q2 2026, up 335.13% year-on-year from $752190.2 in Q2 2025, and up 544.29% on a QoQ basis from $508000.0 in Q4 2025.
Enovis (ENOV) Other Non Operating Income (2018 - 2026) Analysis & Trends
Enovis (ENOV) has 8 years of Other Non Operating Income data on file, last reported at $3.3 million in Q2 2026.
- On a quarterly basis, Other Non Operating Income rose 335.13% year-over-year to $3.3 million in Q2 2026; TTM through Apr 2026 was $4.7 million, a 79.58% decrease from a year earlier, with the FY2023 full-year figure at $25.7 million, up 1129.07% from the prior year.
- Other Non Operating Income for Q2 2026 stood at $3.3 million, up from $508000.0 in the prior quarter.
- Over the last five years, Other Non Operating Income for ENOV reached as high as $33.8 million in Q2 2024 and fell as low as -$24.2 million in Q1 2024.
- Historically, Other Non Operating Income has averaged $2.1 million across 5 years, with a median of $448000.0 in 2025.
- On a YoY basis, Other Non Operating Income climbed as much as 4593.49% in 2024 and fell as far as 3766.41% in 2024.
- Year by year, Other Non Operating Income stood at $22.2 million in 2022, then rose by 12.64% to $25.0 million in 2023, then tumbled by 139.22% to -$9.8 million in 2024, then surged by 105.18% to $508000.0 in 2025, then soared by 544.29% to $3.3 million in 2026.
- Per Business Quant data, the three most recent Other Non Operating Income figures were $3.3 million in Q2 2026, $508000.0 in Q4 2025, and $448000.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Enovis | 1.61 Bn | 1.58 Bn | 365.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 3.27 Mn |
| Dec 31, 2025 | 508,000.00 |
| Oct 3, 2025 | 448,000.00 |
| Jul 4, 2025 | 436,000.00 |
| Apr 4, 2025 | -1.39 Mn |
| Dec 31, 2024 | -9.80 Mn |
| Sep 27, 2024 | 202,000.00 |
| Jun 28, 2024 | 33.84 Mn |
| Mar 29, 2024 | -24.24 Mn |
| Dec 31, 2023 | 25.00 Mn |
| Sep 29, 2023 | 757,000.00 |
| Jun 30, 2023 | -753,000.00 |
| Mar 31, 2023 | 661,000.00 |
| Dec 31, 2022 | 22.19 Mn |
| Jul 1, 2022 | -20.10 Mn |
| Jul 2, 2021 | 29.90 Mn |
| Dec 31, 2019 | -33.62 Mn |
| Sep 27, 2019 | 33.62 Mn |
| Mar 29, 2019 | -43.77 Mn |
| Dec 31, 2018 | 39,000.00 |